Insight Strategy & Marketing Ltd.
Records under this name other than patents Insight Strategy & Marketing Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Insight Strategy & Marketing Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,190,875 | Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe Formerly held Term ended Term ended Jul 10, 2018 · USPTO record | Term ended | Term ended Jul 10, 2018 | USPTO record |
| US 6,177,545 | Heparanase specific molecular probes and their use in research and medical applications Formerly held Term ended Term ended May 1, 2018 · USPTO record | Term ended | Term ended May 1, 2018 | USPTO record |
| US 7,666,651 | Polypeptide having heparanase activity Formerly held Lapsed on the fee record Ended Feb 23, 2018 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2018 | USPTO record |
| US 6,348,344 | Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same Formerly held Term ended Ended no later than Sep 2, 2017 · USPTO record | Term ended | Ended no later than Sep 2, 2017 | USPTO record |
| US 6,426,209 | Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same Formerly held Term ended Term ended Sep 2, 2017 · USPTO record | Term ended | Term ended Sep 2, 2017 | USPTO record |
| US 6,531,129 | Heparanase specific molecular probes and their use in research and medical applications Formerly held Term ended Term ended Sep 2, 2017 · USPTO record | Term ended | Term ended Sep 2, 2017 | USPTO record |
| US 6,699,672 | Heparanase specific molecular probes and their use research and medical applications Formerly held Term ended Ended no later than Sep 2, 2017 · USPTO record | Term ended | Ended no later than Sep 2, 2017 | USPTO record |
| US 6,946,131 | Heparanase activity neutralizing anti-heparanase monoclonal antibody Formerly held Term ended Ended no later than Sep 2, 2017 · USPTO record | Term ended | Ended no later than Sep 2, 2017 | USPTO record |
| US 6,960,471 | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells Formerly held Term ended Term ended Sep 2, 2017 · USPTO record | Term ended | Term ended Sep 2, 2017 | USPTO record |
| US 7,049,407 | Heparanase Specific Antibodies and Their Use in Research and Medical Applications Formerly held Term ended Ended no later than Sep 2, 2017 · Low confidence | Term ended | Ended no later than Sep 2, 2017 | Low confidence |